Pca

3

Review clinical trials related to Pca. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion

This study aims to compare the analgesic efficacy of multiple mid-transverse process to pleura (MTP) block and PCA in idiopathic scoliosis patients undergoing posterior spinal fusion surgery.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Tanta UniversityUpdated: Jan 7, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years. [+3]

Patients with pre-existing infection at block site. [+7]

Status: Recruiting

PSMA PET Combined With MRI for the Detection of PCa

This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).

Participants needed: 204
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Telix Pharmaceuticals (Innovations) Pty LimitedUpdated: Sep 10, 2025Locations: 1
Eligibility criteria

Male, at least 18 years old. [+7]

Has had prior treatment for PCa or prior diagnosis of csPCa. [+11]

Status: Recruiting

Dual-chamber Patient-controlled Analgesia for Postoperative Recovery

Postoperative nausea and vomiting (PONV) are the most common complications that can occur after general anesthesia. Postoperative use of opioids and morbid obesity have been reported as risk factors of PONV. In this study, the investigators aimed to compare the degree of postoperative side effects and pain control when an intravenous patient-controlled analgesia combining fentanyl and ketorolac via a dual-chamber device was provided to participants undergoing laparoscopic sleeve gastrectomy.

Participants needed: 92
Trial details
Age: 19-65Biological sex: FemaleType: InterventionalSponsor: Seoul National University Bundang HospitalUpdated: Jul 3, 2025Locations: 1
Eligibility criteria

Adult females aged 19 to 65 years [+3]

Patients with hypersensitivity to the drugs used in this study (Ketorolac, Fenta... [+9]